


MD PhD @Oslounivsykehus, rheumatologist with special interest in scleroderma, ILD, PAH, biomarkers and microbiome.


Thanks @EuroRespSoc for an exciting #ERSCongress🫁 and the opportunity to present findings on upfront treatment in SSc-PAH from #EUSTAR👀✅. The joint lecture by the fantastic @hoffmann_vold and her incredible colleagues showed the huge interest in the field #RheumPulm 🤩

Thanks to @EuroRespSoc for inviting us to talk at this fully booked postgraduate course, @ILDIPFDoc_NI @PilarRiveraOrt1 @atzouvelekis @DrPeter_George Maria Molina-Molina, George Margaritopoulps and Claudia Ravaglia

📽️ Prof. Anna-Maria Hoffmann-Vold gave us a review of the most recent data from the diagnosis to the management of interstitial lung disease in RMDs at #EULAR24. -> medicaldigest.org/scientific… @eular_org @hoffmann_vold @Oslounivsykehus #Rheumatology #MedTwitter #ILD

Thank you @eular_org for an amazing and inspiring week and the invitation to talk about “What is new in ILD” and all accepted abstract presentations from our group and @EUSTAR_org. Very proud of our teams. @HavardFretheim, @CosimoBruni, @Hildejbjork, @CampochiaroCor

Thank you @ACRheum for great days in San Diego, meeting friends and colleagues, discussing and smiling. So glad we can meet onsite again🥰 @Juge_P_A @Hildejbjork @CosimoBruni @Unispital_USZ @Oslounivsykehus

Very proud of @Hildejbjork for her amazing PhD work and the interview @ACR #ACR23
#ACR23 #postersession Comparison of Four Risk Stratification Models for Prediction of Mortality in Systemic Sclerosis-associated Pulmonary Arterial Hypertension in the EUSTAR Cohort acrconvergencetoday.org/comp…


My 1st in-person talks in Europe after 4 years‼️ Thursday: Pathophysiology of ILD - Lessons & implications for therapy from Single Cell profiles of the IPF Lung Friday: Pathophysiology of ILD - converging & diverging immune pathways in fibrotic lung disease U of Zurich & hybrid

´Clinical Trial Simulations in Pulmonary Fibrosis - patient focused insights adaptations’. Delighted our paper is just out in ERJ Open Research DOI: 10.1183/ 23120541.00602-2022. @TobyMMaher @IPFWarrior @sharonlee88 @flewett @hoffmann_vold @michael_kreuter @Boehringer #CurePF

Very happy to share our recent paper assessing enrichment strategies for progressive ILD in systemic sclerosis in EUSTAR published in Chest @accpchest @EUSTAR_org sciencedirect.com/science/ar…

Today is international day for women in science. #womeninscience Very happy to be one of them👩🏻⚕️👩🏻🔬



Exciting days at #ACR22 with great scientific sessions and meeting wonderful friends again, this evening at the @TheLancetRheum reception with Anna and Heather and finally meeting lovely @DrPujaMehta1

Join the Northern Ireland and Manchester ILD conference.
Check out "Northern Ireland and Manchester Interstitial Lung Disease 2 Day Conference" eventbrite.com/e/northern-ir… @Eventbrite